Announced Fri, 25 Jul · 17:35 IST

Dhampur Bio Organics Limited has informed the Exchange about the grant of stock options pursuant to DBO Employee Stock Option Scheme 2025 as approved by the Nomination and Remuneration Committee.

Capital Market Events View source PDF

DBOL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Dhampur Bio Organics has granted 3,57,881 stock options to eligible employees under its DBO Employee Stock Option Scheme 2025, approved by the Nomination and Remuneration Committee on July 25, 2025. Each option is convertible into one equity share of face value Rs. 10, with an exercise price fixed at Rs. 40 per share. The options will vest in four equal annual installments of 25% each, starting after a minimum 1-year vesting period, and are linked to performance criteria. Once vested, employees have 5 years to exercise the options. The scheme is fully compliant with SEBI's Share Based Employee Benefits Regulations, 2021.

Likely market impact

This is a routine employee incentive announcement with mild future dilution potential of up to 3,57,881 shares (a small portion of share capital) once options are exercised. Shareholders may view it neutrally as a retention tool, with no immediate impact on earnings or share price.